The total return over the past 12 months is -54.46% vs. +16.94% for the S&P 500. So far it's up +46.80% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (54.46%) | (22.00%) | (44.27%) | N/A | N/A | N/A |
| Total Return CAGR | (54.46%) | (22.00%) | (44.27%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | (5.39%) | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Werewolf Therapeutics, Inc. (HOWL)
| Year | Start price | End price | HOWL Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $0.63 | $0.93 | +46.80% | +14.51% | +32.29% |
| 2025 | $1.48 | $0.63 | (57.20%) | +17.72% | (74.92%) |
| 2024 | $3.86 | $1.48 | (61.66%) | +24.89% | (86.55%) |
| 2023 | $2.05 | $3.86 | +88.29% | +26.19% | +62.10% |
| 2022 | $11.91 | $2.05 | (82.79%) | (18.17%) | (64.62%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
